(Q43852424)

27 November 2017

title

Deprenyl protects from MPTP-induced Parkinson-like syndrome and glutathione oxidation in rat striatum (English)

1 reference

27 November 2017

1 reference

1 reference

parkinsonian syndrome

1 reference

Leret ML

1

1 reference

27 November 2017

San Millán JA

2

1 reference

27 November 2017

Fabre E

3

1 reference

27 November 2017

Gredilla R

4

1 reference

27 November 2017

Barja G

5

1 reference

27 November 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

27 November 2017

1 reference

27 November 2017

volume

170

1 reference

27 November 2017

issue

3

1 reference

27 November 2017

page(s)

165-171

1 reference

Age- and peroxidative stress-related modifications of the cerebral enzymatic activities linked to mitochondria and the glutathione system

27 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

The ability of (-)deprenyl to increase superoxide dismutase activities in the rat is tissue and brain region selective

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

The effect of a long term (6 months) treatment with (-)deprenyl on antioxidant enzyme activities in selective brain regions in old female Fischer 344 rats

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

Irreversible inhibition of mitochondrial complex I by 1-methyl-4-phenylpyridinium: evidence for free radical involvement

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

Pharmacology of selegiline

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

Pharmacological basis of the therapeutic effect of (-)deprenyl in age-related neurological diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

Mitochondrial poisons cause depletion of reduced glutathione in isolated hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

Effect of delta 9-tetrahydrocannabinol on short-term memory in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

L-deprenyl protects mesencephalic dopamine neurons from glutamate receptor-mediated toxicity in vitro.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

Etiology and pathogenesis of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

The effect of deprenyl and levodopa on the progression of Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

Effects of tocopherol and deprenyl on the progression of disability in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

Aminoethylcysteine ketimine decarboxylated dimer protects submitochondrial particles from lipid peroxidation at a concentration not inhibitory of electron transport

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

Alkaline hydrolysis of N-ethylmaleimide allows a rapid assay of glutathione disulfide in biological samples

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

Mitochondrial complex I deficiency in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

Monoamine oxidase: from genes to behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

Dopamine turnover and glutathione oxidation: implications for Parkinson disease

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

Modulation of gene expression rather than monoamine oxidase inhibition: (-)-deprenyl-related compounds in controlling neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

Glutathione depletion in rat brain does not cause nigrostriatal pathway degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

Differential effects of L-deprenyl on MPP+- and MPTP-induced dopamine overflow in microdialysates of striatum and nucleus accumbens

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

Effect of MAO-B inhibitors on MPP+ toxicity in Vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

Glutathione depletion potentiates MPTP and MPP+ toxicity in nigral dopaminergic neurones.

1 reference

https://api.crossref.org/works/10.1016%2FS0300-483X%2801%2900541-8

7 January 2021

10.1016/S0300-483X(01)00541-8

Identifiers

DOI

1 reference

27 November 2017

1 reference